Desk›Services› Norris Medicines Ltd
Norris Medicines Ltd
BSE 524414 · NSE NORRIS · ISIN INE744C01029 · Group X · Active
Services › Services › Commercial Services & Supplies › Trading & Distributors
₹15.64
+0.45%
BSE close, 28 August 2026
₹15.64 cr
1.0 cr shares · Micro cap
₹10.32 cr
as published
— · -1.09×
EPS — · BV ₹-14.35
8.13 / -0.28
₹ cr, as filed
15
4 selected · 27%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -20.3% |
|---|---|
| Against 52-week low | +30.3% |
| Day change | +0.45% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | — |
|---|---|
| Price / earnings | — |
| Price / book | -1.09× |
| Book value — derived, price ÷ P/B | ₹-14.35 |
| Return on equity | -0.29% |
| Operating margin | -30.49% |
| Net margin | -42.92% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 0.93 | -0.40 | -0.40 | -30.49% | -42.92% |
| Mar-26 · Q | 1.41 | 0.05 | 0.05 | 23.30% | 3.62% |
| FY25-26 | 8.13 | -0.28 | -0.28 | 8.73% | -3.46% |
Quarter on quarter
- Revenue, quarter on quarter
- -34.0%
- Net profit, quarter on quarter
- -900.0%
- Operating margin, quarter on quarter
- -5,379 bps
Disclosure profile 15 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 2 |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 4 |
| General | 2 |
| Outcome | 2 |
| Annual Report | 1 |
| Book Closure | 1 |
| Newspaper Publication | 1 |
| Procedural sub-total | 11 |
| Total | 15 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
15 filings · 4 selected · busiest 2026-09-29
Filing rhythm · the twelve most recent
2026-08-142026-09-29
SelectedProcedural
Filings
15 in the window · 2 earlier on record
-
29 September 2026 ·
Scrutinizer's Report And Voting Results Of The 35Th AGM Of The Company Held 29Th September, 2026
Scrutinizer's Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
Company Update / General View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Outcome And Proceeding Of The 35Th Annual General Meeting
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
Company Update / General View filing →
-
29 September 2026 ·
Proceeding Of The Annual General Meeting
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026
AGM/EGM / AGM View filing →
-
7 September 2026 ·
Newspaper Publication
Newspaper advertisement regarding the 35th Annual General Meeting of the Company.
Company Update / Newspaper Publication View filing →
-
4 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report of the Company for the Financial year 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
4 September 2026 ·
Notice Of 35Th Annual General Meeting Of The Company For The Financial Year 2025-26
Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Intimation Of Book Closure For 35Th AGM Of The Company.
Intimation of Book Closure for 35th AGM of the Company
Corp. Action / Book Closure View filing →
-
3 September 2026 ·
Board Meeting Outcome for Of Board Meeting Held On Thurday, 03Rd September, 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Outcome of the Board Meeting on Thursday, 03rd September, 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015
Others / Outcome without intimation View filing →
-
14 August 2026 ·
Change in Management
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September, ....
Company Update / Change in Management View filing →
-
14 August 2026 ·
Financial Results For The Quarter Ended June 30, 2026
Financial Results for the Quarter ended June 30,2026
Result / Financial Results View filing →
-
14 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026, Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Board Meeting held on August 14, 2026 for the quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
30 July 2026 ·
Change in Management
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July, 2026.
Company Update / Change in Management View filing →
-
30 July 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July, 2026.
Outcome of Board Meeting held on Thursday, July 30, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others / Outcome without intimation View filing →
RSS feed for Norris Medicines Ltd · the 50 most recent filings